4.7 Article

Sonosensitizer nanoplatform-mediated sonodynamic therapy induced immunogenic cell death and tumor immune microenvironment variation

Related references

Note: Only part of the references are listed.
Article Chemistry, Multidisciplinary

An ER-Targeting Iridium(III) Complex That Induces Immunogenic Cell Death in Non-Small-Cell Lung Cancer

Lili Wang et al.

Summary: The Ir1 iridium complex induces immunogenic cell death in non-small cell lung cancer cells, triggering an anti-tumor T-cell response and resulting in long-lasting anti-tumor immunity through the activation of ICD. Ir1 is the first Ir-based complex capable of developing an immunomodulatory response by inducing immunogenic cell death.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Article Oncology

Hsp90 inhibitor-loaded IR780 micelles for mitochondria-targeted mild-temperature photothermal therapy in xenograft models of human breast cancer

Tao Zhang et al.

Summary: A novel photosensitizer with mitochondrial targeting based on IR780 iodide and a heat shock protein 90 inhibitor (BIIB021) was synthesized, showing promising potential for reducing cell tolerance to heat and enhancing the effect of mitochondria-targeted mild-temperature photothermal therapy.

CANCER LETTERS (2021)

Article Nanoscience & Nanotechnology

Phase-Transformation Nanoparticle-Mediated Sonodynamic Therapy: An Effective Modality to Enhance Anti-Tumor Immune Response by Inducing Immunogenic Cell Death in Breast Cancer

Yiran Si et al.

Summary: Nanoparticle-mediated sonodynamic therapy can promote anti-tumor immune response of breast cancer cells by inhibiting cell proliferation, promoting apoptosis, increasing CD4 and CD8 T cell subsets, and reducing PD-1 positive T cells, leading to suppressed tumor growth.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)

Review Oncology

Immunological configuration of ovarian carcinoma: features and impact on disease outcome

Jitka Fucikova et al.

Summary: This study comparatively summarizes the humoral and cellular features of primary and metastatic EOC, analyzes their impact on disease outcome, and proposes measures to alter them in support of treatment sensitivity and superior patient survival.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Oncology

Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study

Eric Pujade-Lauraine et al.

Summary: This study compared the efficacy of avelumab alone, avelumab plus PLD, and PLD alone in patients with platinum-resistant or platinum-refractory ovarian cancer. The results showed that neither avelumab plus PLD nor avelumab alone significantly improved progression-free survival or overall survival compared to PLD.

LANCET ONCOLOGY (2021)

Article Engineering, Biomedical

Nanoparticle-mediated convection-enhanced delivery of a DNA intercalator to gliomas circumvents temozolomide resistance

Yongheng Wang et al.

Summary: Nanoparticles releasing an oxaliplatin prodrug and a cationic DNA intercalator within temozolomide-resistant gliomas inhibit tumor growth without causing detectable toxicity. Combining anticancer drugs with distinct mechanisms of action, selective drug release, and convection-enhanced delivery may represent a translational strategy for the treatment of TMZ-resistant gliomas.

NATURE BIOMEDICAL ENGINEERING (2021)

Review Oncology

Endoplasmic reticulum stress signals in the tumour and its microenvironment

Xi Chen et al.

Summary: This review explores how ER stress in the tumor microenvironment can influence the functions of cancer cells and immune cells, leading to vulnerabilities that could be targeted by emerging therapeutic strategies. The tightly regulated processes of protein handling, modification, and folding in the ER determine cell function and survival, and disruptions in ER homeostasis can result in a state of persistent ER stress with pro-tumoral effects in cancer cells and immunomodulatory effects in immune cells.

NATURE REVIEWS CANCER (2021)

Article Chemistry, Multidisciplinary

Endoplasmic Reticulum Targeting to Amplify Immunogenic Cell Death for Cancer Immunotherapy

Hongzhang Deng et al.

NANO LETTERS (2020)

Review Engineering, Biomedical

Prototypic Heptamethine Cyanine Incorporating Nanomaterials for Cancer Phototheragnostic

Miguel M. Leitao et al.

ADVANCED HEALTHCARE MATERIALS (2020)

Review Oncology

Exploiting the folate receptor α in oncology

Mariana Scaranti et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2020)

Article Oncology

PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline

William P. Tew et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Article Chemistry, Multidisciplinary

Magnetic nanoparticles coated with polyphenols for spatio-temporally controlled cancer photothermal/immunotherapy

Fan Zhang et al.

JOURNAL OF CONTROLLED RELEASE (2020)

Article Materials Science, Biomaterials

Mitochondria-targeted nanospheres with deep tumor penetration for photo/starvation therapy

Yong Wang et al.

JOURNAL OF MATERIALS CHEMISTRY B (2020)

Review Chemistry, Multidisciplinary

Multifunctional sonosensitizers in sonodynamic cancer therapy

Subin Son et al.

CHEMICAL SOCIETY REVIEWS (2020)

Article Chemistry, Multidisciplinary

Photothermal cancer immunotherapy by erythrocyte membrane-coated black phosphorus formulation

Xin Liang et al.

JOURNAL OF CONTROLLED RELEASE (2019)

Review Medicine, General & Internal

Epithelial ovarian cancer

Stephanie Lheureux et al.

LANCET (2019)

Review Biotechnology & Applied Microbiology

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

Jerome Galon et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Review Immunology

Cold Tumors: A Therapeutic Challenge for Immunotherapy

Paola Bonaventura et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Oncology

Host tissue determinants of tumour immunity

Helene Salmon et al.

NATURE REVIEWS CANCER (2019)

Review Medicine, Research & Experimental

Photodynamic therapy - mechanisms, photosensitizers and combinations

Stanislaw Kwiatkowski et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Article Oncology

Ovarian Cancer Statistics, 2018

Lindsey A. Torre et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

Review Pharmacology & Pharmacy

IR780 based nanomaterials for cancer imaging and photothermal, photodynamic and combinatorial therapies

Catia G. Alves et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)

Review Oncology

Migrating into the Tumor: a Roadmap for T Cells

Lieke L. van der Woude et al.

TRENDS IN CANCER (2017)

Review Immunology

Immunogenic cell death in cancer and infectious disease

Lorenzo Galluzzi et al.

NATURE REVIEWS IMMUNOLOGY (2017)

Review Biochemistry & Molecular Biology

New photosensitizers for photodynamic therapy

Heidi Abrahamse et al.

BIOCHEMICAL JOURNAL (2016)

Review Oncology

Consensus guidelines for the detection of immunogenic cell death

Oliver Kepp et al.

ONCOIMMUNOLOGY (2014)

Review Oncology

Immunogenic cell death and DAMPs in cancer therapy

Dmitri V. Krysko et al.

NATURE REVIEWS CANCER (2012)

Article Multidisciplinary Sciences

Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice

Mickael Michaud et al.

SCIENCE (2011)

Review Cell Biology

MAM: more than just a housekeeper

Teruo Hayashi et al.

TRENDS IN CELL BIOLOGY (2009)

Article Biochemistry & Molecular Biology

Calreticulin exposure dictates the immunogenicity of cancer cell death

Michel Obeid et al.

NATURE MEDICINE (2007)